IRVINE, Calif.- (Newsworthy AI) – Lionheart Health, Inc., a privately held company that is an innovation leader in healthspan longevity extension technologies and medical aesthetics, today announced that Howard Leonhardt, Executive Chairman and CEO, will present at the Life Science Intelligence (LSI) USA ’25 Emerging Medtech Summit. Scheduled to present March 19th, 2025, at 2:39pm pm PT in Track 4. Leonhardt will share progress on licensing clinics worldwide to carry its patented technology platform and the upcoming full launch of it’s direct to consumer eStore of healthspan extension and aesthetics technologies.Leonhardt remarked, “Our company Lionheart Health, Inc. believes it has established itself as the undisputed leader in aging reversal technologies with a goal to reverse aging 20 years inside and out. Presenting at LSI USA ’25 Emerging Medtech Summit provides us the opportunity to showcase our one-of-a kind patented bioelectric protein expression technology platform applied to regenerating skin and hair, improving sexual wellness, joint health, mental well being, rapid body toning and healthspan longevity extension. It’s a privilege to highlight our pioneering unique innovations designed to reverse aging inside and out led by our Lionheart Klotho Wellness Program. If you are low in circulating klotho you are aging more rapidly than you should and no firm has developed a deeper technology portfolio than Lionheart Health to help people increase their circulating klotho levels.”About Lionheart Health, Inc.:
Lionheart Health, Inc. http://www.lionhearthealthstim.com + http://www.lionheartlongevity.com is a southern California-based, global biotech and medical technology company dedicated to improving patients’ lives by inventing, developing and bringing to market unique one-of-a-kind technologies to extend healthspan longevity and restore youthful beauty. The core technology platform covered by more than 500 patents claims is bioelectric controlled regenerative protein expressions on demand. This is applied to regenerating both internal and external organs. The company’s grandest development project is building the world’s first total body regeneration chamber “a womb for adults”. The company is an official entrant in the $101 million XPrize competition for healthspan. In December 2023 they won the coveted Abbvie Allergan Aesthetics ULP Award for Innovation in Medical Aesthetics.
